Skip to main navigation Skip to search Skip to main content

Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

  • Ronald V. Lacro
  • , Harry C. Dietz
  • , Lisa M. Wruck
  • , Timothy J. Bradley
  • , Steven D. Colan
  • , Richard B. Devereux
  • , Gloria L. Klein
  • , Jennifer S. Li
  • , L. Lu Ann Minich
  • , Stephen M. Paridon
  • , Gail D. Pearson
  • , Beth F. Printz
  • , Reed E. Pyeritz
  • , Elizabeth Radojewski
  • , Mary J. Roman
  • , J. Philip Saul
  • , Mario P. Stylianou
  • , Lynn Mahony

Research output: Contribution to journal › Article › peer-review

197   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology